 On the medical page, the FDA Food and Drug Administration we hear this morning has approved a new Alzheimer's treatment from Eli Lilly, CBS News Chief Medical Correspondent, Dr. John Pellew. Denanamab is the second drug available for Alzheimer's patients with early symptoms. It will be sold under the brand name Kesunla.